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Abstract 
The objectives of this study were to examine the effect of anabolic implants on nutrient 
balance, metabolic status, and growth factors in animals consuming nutrients either adequate or 
inadequate to support growth.  Sixteen crossbred steers (BW 293 ± 19.3 kg) were trained to 
individual Calan gates, and randomly assigned to one of four treatments in a 2x2 factorial 
arrangement: (1) administration of an anabolic growth implant, and fed a moderate energy 
starting cattle diet at 2.0 × maintenance; (2) implant administration, and fed the same starting 
diet at 1.0 × maintenance; (3) no implant, and 2.0 × maintenance; (4) no implant and 1.0 × 
maintenance diet.  Cattle were implanted with RevalorXS, containing 200 mg TBA and 40 mg 
estradiol.  Animals were weighed on d 0, 14, and 28, with total gain, ADG, and feed efficiency  
determined at each time point.  Blood samples were taken from each animal at d 0, 14, and 28 
and used in determining serum concentrations of IGF-1 and plasma urea nitrogen (PUN).  Serum 
collected on d 14, and 28 was applied to satellite cells (previously isolated from non-study steers 
and frozen).  Protein abundance of myosin heavy chain (MYH; d 0, 14, and 28), phosphorylated 
extracellular signal related kinase (pERK; d 0 and 28), and phosphorylated mammalian target of 
rapamycin (pmTOR; d 0 and 28) was analyzed in differentiated satellite cells to determine 
effects of implant, intake, and their interaction (applied via the serum).  There was a significant 
effect of diet on weight (P < 0.0001).  There was a tendancy for an interaction between diet and 
implant on PUN (P = 0.09).  Only diet had an effect on IGF-1 levels (P < 0.001).  Implant 
increased MYH abundance (P < 0.01), and the abundance of pERK (P < 0.01).  At high intake, 
implant increased abundance of pmTOR (P = 0.02) but had no effect on pmTOR at restricted 
intake (P = 0.21; interaction P < 0.01).  These preliminary results show that implantation, which 
  
has previously been shown to improve gain, ADG, and feed efficiency, may not be as beneficial 
in cattle fed a restricted diet. 
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Chapter 1 - The Effects of Nutrient Intake on Steers Administered 
Anabolic Implants:  A Review of the Literature 
 Introduction 
With the expansion of the human population from approximately 2.5 billion people in 
1950 to almost 7 billion people today (U.S. Census Bureau, 2011), there is an obvious need to 
find new and different ways to increase the amount of safe and nutritious food to support this 
ever-growing population.  Numerous research trials have been conducted to advance our 
understanding of the growth and development of plants and animals grown for food purposes, 
and especially that of animals bound for red meat consumption. In turn, our understanding of the 
physiological processes of growth has expanded.  Knowledge of these processes has led to great 
advances in the production of meat for the world’s population.  These advances in production 
will need to continue if we will feed the 9 billion people who are expected to populate our planet 
by the year 2050 (U.S. Census Bureau, 2011).  
One of these advances in production could include increasing the efficiency with which 
animals produce red meat, or, in essence, grow.  Animals must grow larger in a shorter amount 
of time to increase this efficiency.  Efficiency of growth in animals can also be increased if the 
growth can be obtained with less feedstuffs consumed (Hutcheson et al, 1997).  Not only do 
these increases in efficiency help us to produce more red meat in a shorter amount of time, they 
also help to decrease the amount of inputs that must be utilized to produce that amount of meat.  
It has been determined that the use of anabolic steroid implants offers the biggest return on 
investment related to increasing efficiency, outside of providing the most adequate nutrition to 
beef cattle (Montgomery et al, 2001).  Anabolic steroid implants have been shown to increase 
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average daily gains 10 to 21%, and improve feed:gain ratios by 6 to 14% in feedlot cattle 
(Johnson et al, 1996, Duckett & Owens, 1997, Duckett & Andrae, 2001, Bruns et al, 2005).  
Such responses leave little room to argue the use of implants in the beef cattle industry for 
improved efficiency and growth.   
However, this drive for improved efficiency and growth can come with some negative 
consequences.  Many cattle arrive at feedlots in a state of stress because they are not yet 
accustomed to the environment, feeding routine, a new social order, and many other changes 
encountered at this time.  Stress levels can be increased if cattle have been hauled long distances, 
or have recently been weaned from the cow (Loerch & Fluharty, 1999).  These cattle are at 
higher risk for increased morbidity and mortality rates, and for decreased performance in the 
feedlot (Loerch & Fluharty, 1999).  Many of these high-risk cattle have reduced intakes for up to 
three weeks after arrival at the feedlot (Hutcheson & Cole, 1986).  The stress of these events can 
lead to immunocompromised cattle, which lead to an increased risk of bovine respiratory disease 
(BRD) (Blecha et al, 1984), the number one cause of death in cattle and calves in the United 
States (NAHMS, 1994).   
In humans and other non-ruminants, stress and/or infection (such as BRD in cattle) can 
lead to a hypermetabolic state (Cole et al, 1986).  This condition is characterized by weight loss, 
increased resting metabolic rate, and increased muscle protein catabolism (Cole et al, 1986).  
Cattle suffering from bovine respiratory disease often have decreased feed intake, weight loss, 
and decreased body condition (Cole et al, 1986).  Ruminants have a greater capacity to store and 
utilize nutrients because of their larger and more diverse digestive tracts; however, this weight 
loss and decrease in body condition can be comparable to the hypermetabolic state that develops 
in non-ruminants (Cole et al, 1986).  In such high-risk cases, implanting cattle upon arrival at the 
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feedlot has been suggested to be detrimental to their performance, possibly turning that anabolic 
effect into a catabolic state in the muscle tissue. 
 Anabolic Steroid Implants 
The utilization of steroid hormones in anabolic implants dates back to 1947, when 
Hereford heifers were experimentally implanted with diethylstilbestrol (DES), a form of 
synthetic estrogen (Raun & Preston, 2002).  This initial study revealed that steroid implants 
increased rate of gain (approximately 15%), and improved feed efficiency (approximately 10%) 
in cattle, and steroid implants have been studied and documented ever since.  The USDA 
approved the use of DES in feedstuffs in 1954, and as an injectable implant in 1957 (Raun & 
Preston, 2002).  The use of DES was prohibited in cattle, in feedstuff and injectable form, by the 
FDA in 1973 (Raun & Preston, 2002).  However, other growth promotants containing estrogen 
analogs, progesterone, and trenbolone acetate were developed, and are approved by the FDA.   
Today, over 90% of all feedlot cattle are implanted with some form of anabolic implant at least 
once, and usually more than once, before slaughter (Dikeman, 2007). 
There are a number of estrogenic, androgenic, and combination implants approved for 
use in beef cattle today (Table 1).  According to Dikeman (2007), estrogenic compounds are 
generally more effective in steers, while androgenic compounds are usually more effective in 
heifers.  It has been recognized that combination implants containing both trenbolone acetate 
(TBA—an androgen analog) and estradiol are the most effective growth promoters in cattle 
(Duckett & Andrae, 1997, Duckett & Andrae, 2001, Foutz et al, 1990, Johnson et al, 1996, 
Thomson et al, 1996). 
Estrogenic and androgenic implants increase growth by increasing protein accretion in 
muscle tissue (Foutz et al, 1997).  The increased muscle tissue protein accretion results in 
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increased average daily gain (ADG) and increased hot carcass weight in cattle (Duckett & 
Andrae, 2001).  Cattle implanted with steroid hormones also have improved feed efficiency 
(Guiroy et al, 2002).  As previously stated in this review, anabolic implants have been shown to 
increase average daily gains 10 to 21%, and improve feed:gain ratios by 6 to 14% in feedlot 
cattle (Johnson et al, 1996, Duckett & Owens, 1997, Duckett & Andrae, 2001, Bruns et al, 2005) 
compared to cattle not treated with steroid implants.      
Steroid implants have been determined to aid the industry in producing an increased 
amount of lean beef with a reduced amount of feed utilized.  However, there have been some 
industry concerns about the impact of implants on carcass traits (Foutz et al, 1997, Morgan et al, 
1997, Dikeman, 2007).  Decreased marbling, decreased palability of beef and decreased 
tenderness of meat, are producer concerns when using steroid implants in cattle (Foutz, et al, 
1997, Morgan et al, 1991).  Nichols et al. (2002) reviewed the effects of steroids implants on 
beef tenderness.  In their review, they found that only three out of 19 studies showed negative 
effects of steroid implants on beef tenderness as determined by Warner-Bratzler shear force 
scores compared to beef from non-implanted cattle.  It should be noted that two studies actually 
reported an increase in tenderness of beef from implanted cattle compared to that from non-
implanted cattle.  Because of the differences in the results of these studies, it must be considered 
that there may be no difference in tenderness, and these results showing increased or decreased 
tenderness could be due to chance.  Such pros and cons of the use of anabolic implants in beef 
production have led to the use of multiple implant strategies throughout the beef production 
circuit in an effort to maximize the performance of different cattle types in different 
environments, with different resources, throughout the country. 
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There are many different steroid implant strategies used by beef producers today.  Cattle 
can be implanted as suckling calves, stocker cattle, yearlings, and at many other points in the 
marketing process.  Different steroid implant strategies can be used for increased production in 
heifers versus steers (Montgomery et al. 2001).  It has been shown that implanting steers with an 
androgenic, estrogenic or acombination (androgen + estrogen) implant has a positive effecs on 
body weight, ADG, and F:G mentioned previously in this paper (Foutz et al, 1997, Duckett & 
Owens, 1997).  However, when implanting heifers, a meta-analysis done by Wileman et al. in 
2009 showed that implanting improved only average daily gain, and not feed:gain or dry matter 
intake.  However, this could possibly be attributed to different diets being fed among the studies 
included in this meta-analysis.  According to Duckett and Andrae (2001), a strategy that utilizes 
a combination implant at two different times while the cattle are in the feedlot has been reported 
as the most effective strategy when increased average daily gain and feed efficiency are desired.   
  It is common strategy to implant cattle upon arrival at the feedlot, and then at 
approximately 100 days prior to slaughter.  In 2007, a new long-lasting steroid implant was 
approved by the FDA.  This implant eliminates the need to re-implant cattle at 100 days prior to 
slaughter, and therefore eliminates a potential source of stress for the cattle, and expense for the 
feedlot.  Revalor XS (Merck, Summit, NJ) consists of 200 mg of TBA and 40 mg of estradiol per 
dose.  The implant is a time-release product that dispenses a regular dose of steroid hormones, 
based on the plastic coating technology that surrounds the implant (Intervet Schering-Plough 
Animal Health).  Such a mechanism of delivery may reduce labor costs and stress due to 
processing, while still providing the necessary implant for the desired improvement in 
performance. 
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 Skeletal Muscle Growth and Muscle Satellite Cells 
The growth of skeletal muscle tissue involves a unique and complex series of events. The basic 
cellular unit of muscle tissue is the muscle fiber.  Most muscle fibers are formed during 
embryonic growth, and the formation of fibers does not continue appreciably after birth in most 
mammals.  Postnatal skeletal muscle growth, or hypertrophy, can be attributed to both an 
increase in diameter and length of the muscle fibers.  Skeletal muscle hypertrophy is regulated by 
at least three major molecular processes: satellite cell activity, gene transcription and protein 
translation (Machida & Booth, 2004).     
 Most muscle fibers and the nuclei within them are post-mitotic after birth, resulting in the 
inability to divide (Allen et al, 1979).  A correlation between the amount of DNA in the muscle 
cells and muscle weight during growth was shown by Trenkle et al (1978).  Continued growth of 
muscle fibers can be accomplished with hypertrophy of the cells, but this hypertrophy must be 
sustained by an external source of DNA (Moss & LeBlond, 1970).  Multiple studies have shown 
that, postnatally, there is an increase in the amount of DNA content in the muscle fibers of 
various mammals (Winick & Noble 1966, Moss 1968, Johns and Bergen 1976,).  This external 
source of DNA is the muscle satellite cell (Moss & LeBlond, 1970).    
 Satellite cells were discovered by Alexander Mauro in 1961, using electron microscopy 
of the peripheral region of the skeletal muscle of frogs.  At the time of his discovery, Mauro 
hypothesized on the purpose of these cells, but it wasn’t until the 1970’s that the true function of 
muscle satellite cells was discovered.  In 1970, Moss and LeBlond concluded that the satellite 
cells associated with skeletal muscle fibers are capable of undergoing mitosis, and this mitosis is 
the source of DNA for the true muscle fibers.  This conclusion was reached after thymidine-3H 
was incorporated into satellite cell nuclei and then subsequently found in the nuclei of the 
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associated true muscle fibers.  After the incorporation of the satellite cell into the true muscle 
fiber, the satellite cell nuclei lose their capacity to proliferate (Moss and LeBlond, 1971).   
 It is this process of satellite cell proliferation and the subsequent incorporation of external 
DNA into true muscle fibers that allows postnatal hypertrophy of muscle tissue (Johnson et al, 
1998).  However, satellite cells are not in a continuous state of proliferation.  They reside in a 
state of quiescence, and must be stimulated by hormones to progress through the cell cycle.  It 
has been found that the progression factor insulin- like growth factor 1 (IGF-1) is a stimulant of 
this proliferation (Johnson et al, 1998).   
 Signalment of Skeletal Muscle Growth and the Effects of Implantation 
IGF-1 is a peptide hormone synthesized and secreted mainly from the liver, that mediates 
the growth-promoting actions of growth hormone (Hong & Forsberg, 1994).  The anabolic 
effects of IGF-1 on skeletal muscle cells and satellite cells include stimulation of amino acid 
uptake, protein synthesis, glucose uptake, DNA and RNA synthesis, cell proliferation, and cell 
differentiation (Hong & Forsberg, 1994, Machida & Booth, 2004).   
Johnson and others (1996) concluded that circulating levels of IGF-1 were increased in 
steers implanted with a combined TBA/E2 implant as compared to control steers, given no 
implant.  It has also been shown that a combined TBA and estradiol implant can increase the 
time in which satellite cells become activated in culture (Johnson et al, 1998).  An increase in 
IGF-1 production and satellite cell activation of implanted cattle contributes to the positive 
effects of implantation on enhancing protein accretion in growing true muscle cells.  This has led 
to the inference that implants directly or indirectly activates quiescent muscle satellite cells in the 
body, therefore enhancing growth (Johnson et al, 1998).  
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This muscle growth, or more specifically, protein synthesis, can be indirectly measured in 
vivo by the determination of the amount of nitrogen in the plasma of these animals (Sastry & 
Kravtchenko, 1980).  Steroid implants are not involved directly in the deposition of protein in 
muscle cells, but rather in the signalment of the body to increase protein synthesis.  Therefore, 
the amount of nitrogen in an animal’s plasma can provide useful information to help determine 
whether that synthesis is in fact happening (Thomson et al, 1996).   
There are three ways in which the amount of nitrogen in the plasma of an animal can be 
changed—changes in protein synthesis, changes in protein degradation, or both.  Anabolic 
growth implants affect the element of protein synthesis in the case of beef cattle.  These implants 
increase the utilization of nitrogen for the use of the aforementioned synthesis of protein 
(Thomson et al, 1996).   Because more of the body’s nitrogen store is being used in those 
implanted animals, it has been shown that urea nitrogen levels in the plasma of implanted steers 
versus non-implanted steers is lower (Thomson et al, 1996). 
It has been hypothesized that the synthesis of proteins could be in response to the 
activation of certain pathways regulated by activation factors, specifically mammalian target of 
rapamycin (mTOR) and extracellular signal-related kinases (ERK).  It has been hypothesized 
that the administration of anabolic implants increases the activation of these pathways, or the 
amount of signaling kinases that control these pathways (Figure 1.1).  The phosphorylation of 
these signalment proteins may indicate the ―turning on‖ or ―turning off‖ of certain cellular 
pathways that increase muscle protein synthesis, and therefore, muscle growth.  The ERK protein 
plays an important role in cell proliferation and differentiation (Lai et al, 2001).  mTOR has been 
shown to play an essential part in the regulation of many cellular activities, including 
transcription, translation, cell size, and protein stability (Corradetti & Guan, 2006).  To help 
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regulate these processes, mTOR integrates information about nutrient status, energy status, and 
many growth factors (Sorbassov et al, 2005).  It is because of this integration and its effects on 
so many different cellular activities that mTOR could be helpful in determining the effects of 
implantation and nutrient availability in beef cattle. 
 Stress Experienced by Newly-arrived Cattle in the Feedyard 
As cattle move through the normal livestock marketing system, they are subject to a number of 
different stressors (Hutcheson & Cole, 1986).  Such stressors include weaning, feed and water 
deprivation, crowding, and introduction to infectious agents (Hoerlein & Marsh, 1957).  After 
arrival at the feedlot, cattle can be exposed to other stressors such as processing, including 
castration, dehorning, vaccination, deworming, and implantation (Hutcheson & Cole, 1986).  
These stressors can be characterized in the animal by transient endocrine responses, alterations in 
products of energy and protein metabolism, changes in appetite and growth rate, compromised 
digestion and rumen function, and challenges to an animal’s immune system (Loerch & Fluharty, 
1999). 
 Transportation stress can have a huge impact on newly arrived cattle.  Shrink, or loss of 
body weight, during transportation can be attributed to dehydration, rumen stasis, the depletion 
of nutrients in the digestive tract due to urine and fecal loss, and tissue loss due to stress 
(Hutcheson & Cole, 1986).  Overcrowding, poor air quality, and poor sanitation during long 
hauls can exacerbate these problems (Loerch & Fluharty, 1999). 
Management is critical to optimize cattle performance when stressed cattle arrive at the 
feedlot.  It can take up to 4 days before healthy cattle start eating, depending on previous 
environment and length of transport, and even longer for cattle that have been affected by disease 
(Hutcheson & Cole, 1986).  Even after these cattle start to eat, appetite may be decreased for up 
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to 1 to 3 weeks after arrival (Hutcheson, 1980).  This nutritional deficiency can interact with the 
stress of weaning, comingling, and/or processing, along with exposure to new infectious agents 
to cause a large compromise in immune function (Galyean, et al. 1999). 
Numerous studies have shown that the response and performance of feedlot cattle during 
the overall feeding period is affected by their health and performance response during the 
receiving/starting period (Roeber et al, 2001, Owens & Gardner, 1999, Snowder, 2007, Garcia et 
al, 2010). Thus, the receiving period plays a crucial role in the economic outcome of cattle 
feeding (Hicks, 2010). 
 Bovine Respiratory Disease in Newly-arrived Feedlot Cattle 
Bovine Respiratory Disease continues to be the most significant health problem in newly 
weaned and/or received feedlot cattle (Duff & Galyean, 2007).  According to Snowder (2007), 
BRD is the most costly feedlot disease in the United States.  The pathogens that cause BRD are 
viral, bacterial, or both.  Mannheimia haemolytica serotype 1 is the most common bacterial 
pathogen associated with BRD (Pandher, et al, 1998).  Other bacterial species contributing to the 
disease can include Mycoplasma species, and Histophilus somni.  Viral agents include infectious 
bovine rhinotraceitis (IBR), parainfluenza-3 (PI3), bovine viral diarrhea virus (BVDV), bovine 
respiratory syncytial virus (BRSV), and bovine enteric coronavirus (Duff & Galyean, 2007). 
 However, the BRD complex is a multifaceted problem (Duff & Galyean, 2007).  
Contributing factors such as weaning, marketing, transportation, genetics, and history can have 
negative effects on immune function (Duff & Galyean, 2007).  This stress can be compounded 
by a decrease in feed intake for up to 3 weeks after cattle arrive at the feedlot (Hutcheson, 1980).  
At this time, cattle are exposed to many new different infectious agents due to comingling with 
other animals from different origins (Duff & Galyean, 2007).  The stressed and naïve animals are 
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exposed to new pathogens, leading to an increase in the likelihood of cattle contracting the 
agents that cause BRD.   
While most animals entering a feedlot are vaccinated against the majority of these 
pathogens, clinical disease can spread very easily in an environment which houses thousands of 
animals from hundreds of sources at one time.  Feedlot staff are trained to recognized these cases 
of clinical disease throughout the feedlot.  Clinical signs of BRD include nasal or ocular 
discharge, depression, lethargy, emaciated body condition, or labored breathing (Duff & 
Galyean, 2007).  Symptomatic cattle with a rectal temperature ≥39.7°C are usually considered 
morbid and given therapeutic antibiotic treatment (Duff & Galyan, 2007).  Most animals are 
removed for examination and treatment for BRD on or before d 27 of the receiving period 
(Buhman et al, 2000). 
 Effects of Implantation on Disease Status 
Many cattle are in a state of stress at feedlot arrival and have not yet become accustomed 
to the environment, feeding routine, etc.  These high-risk cattle may have reduced intakes for up 
to three weeks after arrival at the feedlot (Hutcheson & Cole, 1986).  Subsequent 
immunosuppression leads to an increased risk of bovine respiratory disease (BRD) (Blecha et al, 
1984).   
It has been hypothesized that implanting cattle with steroid implants upon arrival at the 
feedlot could be detrimental to their health, and therefore to their overall performance because of 
increased metabolic activity at a time in which they are not consuming feed.  When cattle are 
stressed, such as during or immediately after transport, or during/after routine processing 
procedures (vaccinating, implanting, castrating, dehorning, etc.), intake is usually depressed 
(Hutcheson & Cole, 1986).  This stress and decreased intake can result in disease, particularly 
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BRD, which could be exacerbated in implanted cattle compared to non-implanted cattle. (Duff & 
Gaylean, 2007).   
It has been observed that weight loss and decreases in body condition are typical in cattle 
affected by BRD (Cole et al, 1986).  Questions to ask include: could the increase in nutrient 
requirements needed due to anabolic steroid implants have detrimental effects in such a 
situation?  Also, can these anabolic steroid implants in fact create a catabolic state in cattle when 
the nutrient requirements are not met? 
Therefore, the objectives of this thesis are to: 
1. Examine the impact that anabolic implants may have on animals in a restricted 
nutritional state. 
2. Evaluate the concentrations of certain signaling proteins and their involvement on 
myosin heavy chain expression in primary skeletal muscle cell culture 
3. Determine if the two previous objectives may be linked in some way on a cellular 
level, and if that link can be extrapolated to use in decision-making when 
considering implant strategies in a large commercial feedyard. 
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 Tables & Figures 
Table 1.1: Commercial implants available today. 
Category Trade name Ingredients Dosage (mg) Suitable cattle type  
Mild estrogens         
 
Compudose
a
 Estradiol 25.7 Steers and heifers 
 
Encore
b
 Estradiol 43.8 Steers and heifers 
 
Ralgro
c
 Zeranol 36 All cattle 
 
Implus-C
d
 Progesterone 100 Steers and heifers 
 
Component E-C
a
 Progesterone 100 Steers and heifers 
 
Synovex-C
e
 Estradiol benzoate 10 Steers and heifers 
Strong estrogens         
 
Ralgro Magnum
c
 Zeranol 72 Steers 
 
Implus-S
d
 Progesterone 100 Steers 
 
Component E-S
a
 Progesterone 20 Steers 
 
Syonvex-S
e
 Estradiol benzoate 20 Steers 
Androgens         
 
Component T-S
a
 Trenbolone acetate 140 Steers 
 
Finaplix-H
d
 Trenbolone acetate 200 Heifers 
 
Component T-H
a
 Trenbolone acetate 200 Heifers 
Mild combination         
 
Implus-H
d
 
Testosterone proprionate 
Estradiol benzoate 
200                   
20 Heifers 
 
Synovex-H
e
 
Testosterone proprionate 
Estradiol benzoate 
200                   
20 Heifers 
 
Component E-H
a
 
Testosterone proprionate 
Estradiol benzoate 
200                   
20 Heifers 
 
Revalor-S
d
 
Trenbolone acetate                
Estradiol 
120                  
24 Steers 
 
Component TE-S
a
 
Trenbolone acetate                
Estradiol 
120                  
24 Steers 
 
Revalor-H
d
 
Trenbolone acetate                
Estradiol 
140                   
14 Heifers 
 
Revalor-G
d
 
Trenbolone acetate                
Estradiol 
40                       
8 Steers and heifers 
 
Revalor-IH
d
 
Trenbolone acetate                
Estradiol 
80                       
8 Heifers 
 
Revalor-IS
d
 
Trenbolone acetate                
Estradiol 
80                      
16 Steers 
 
Component TE-G 
Trenbolone acetate                
Estradiol 
40                        
8 Steers and heifers 
Strong combination       
 
Synovex Plus
e
 
Trenbolone acetate              
Estradiol benzoate 
200                    
28 Feedlot steers and heifers  
 
Revalor-200
d
 
Trenbolone acetate              
Estradiol benzoate 
200                    
20 Steers 
  Revalor-XS
d
 
Trenbolone acetate                
Estradiol 
200                    
40 Feedlot steers and heifers  
*Table modified from that listed in Montgomery et al, 2001    d Intervet-Schering-Plough (Madison, NJ) 
a
 Elanco Animal Health (Greenfield, IN)     
e
 Pfizer Animal Health (Madison, NJ) 
b
 Vet live (Winterset, IA) 
cMerck Animal Health (Summit, NJ 
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Figure 1.1: ERK Cascade 
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Chapter 2 - The Effects of Nutrient Intake on Steers Administered 
Anabolic Implants 
 Introduction 
Anabolic implants have been shown to increase average daily gains 15 to 20%, and 
improve feed efficiency by 6 to 14% in feedlot cattle (Duckett & Andrae, 2001).  However, 
when animals first arrive in a feedlot, many are in a state of stress and have not yet become 
accustomed to the environment, feeding routine, social structure, and other factors, especially if 
they have traveled long distances, or have recently been weaned.  These cattle are determined to 
be ―high risk‖ cattle; i.e. they are considered at high risk to develop bovine respiratory disease 
(BRD).  Many of these high-risk cattle have reduced intakes for up to three weeks after arrival at 
the feedlot (Hutcheson & Cole, 1986), which further predisposes them to develop BRD. 
In humans and other non-ruminants, stress and/or infection can lead to a hypermetabolic 
state, characterized by weight loss, increased resting metabolic rate, and increased muscle 
protein catabolism (Cole et al, 1986).  In cattle infected with BRD, decreased feed intake, weight 
loss, and decreased body condition are often observed (Cole et al, 1986).  Although ruminants 
may have a greater capacity to store and utilize nutrients because of their larger and more diverse 
digestive tracts, this weight loss and decrease in body condition may be comparable to the 
hypermetabolic state that develops in non-ruminants (Cole et al, 1986).  In such high-risk cases, 
it has been suggested that implanting cattle upon arrival at the feedlot could be detrimental to 
their performance, further increasing stress and complicating existing risk factors.  The objective 
of this study was to examine the effects of anabolic implants on measures of nutrient balance, 
metabolic status, and growth factors in animals consuming nutrients either adequate or 
inadequate to support growth. 
24 
 
 Materials & Methods 
 Animals 
Sixteen crossbred (predominantly continental breed) steers were purchased locally and 
transported to Kansas State University, and housed in accordance with university Institutional 
Animal Care and Use Committee guidelines.  They were weighed, tagged, and vaccinated with a 
5-way respiratory viral vaccine and a 7-way clostridial vaccine.  The steers were trained to 
individual Calan® gates over a period of 2 weeks.   
After training was complete, the steers were randomly assigned to one of four treatments 
in a 2 × 2 factorial arrangement:  (1)  administration of an anabolic growth implant (Revalor-XS: 
200 mg trenbolone acetate and 40 mg estradiol 17-β; Merck, Whitehouse Station, NJ), and 
provided 2.0 x maintenance of a moderate energy starting cattle diet; (2) administration of the 
same implant, but fed the with aforementioned diet at 1.0 × maintenance;  (3) no implant 
administered, and provided 2.0 x maintenance of the same starting diet; (4) no implant and fed at 
1.0 × maintenance.  Cattle were fed a total mixed pelleted ration (Table 1). 
Animals were weighed on d 0, 14, and 28 of the trial, after being fasted overnight.  At 
each of these time points, maintenance requirements were calculated for each steer (NRC, 1984), 
and rations were fed based these calculations and the treatment assignment of each steer.   
 Biochemical Assays 
Blood samples (serum and plasma) were taken from each animal at d 0, 14, and 28 of the 
trial and used in determining levels of IGF-1 and plasma urea nitrogen (PUN).  The serum 
collected was also applied to satellite cells which had been previously isolated from the 
semimembranosus muscle of two non-study steers and frozen in liquid nitrogen.  Satellite cells 
were incubated with serum of individual animals from d 14 and 28 (20% of total media) for 72 h.  
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Protein abundance of myosin heavy chain (MYH; d 0, 14, and 28), phosphorylated extracellular 
signal related kinase (pERK; d 0 and 28), and phosphorylated mammalian target of rapamycin 
(pmTOR; d 0 and 28) was analyzed in differentiated satellite cells to determine effects of 
implant, intake, and their interaction (applied via the serum).  MYH is used as a marker of 
myotube formation, and pERK and pmTOR are growth factor protein indicators of cell 
proliferation.   
 Statistical Analysis 
Animal was the experimental unit for all measures.  Data were analyzed using the GLM 
procedure of SAS® (v. 9.1.3; SAS Institute, Cary, NC); IGF-1 and PUN were analyzed using a 
repeated measures.  The independent variables included the main and interactive effects of 
implant status and intake.  Effects were considered significant based on a protected F-test with α 
< 0.05. 
 Results & Discussion 
 Body Weight 
No significant interactions were noted in the analysis of body weight.  There was an 
increase in the weight of the steers fed the 2 × maintenance diet (P < 0.01), but implantation had 
no significant effect.  It is well understood that estrogenic and androgenic implants increase 
growth by increasing protein accretion and muscling (Foutz et al, 1997).  This, in turn results in 
increased average daily gain (ADG) and increased hot carcass weight (Duckett & Andrae, 2001).  
However, with the data gathered in this study, the difference in body weight between the study 
groups cannot be attributed to implantation alone.  Only those steers fed at a 2 × maintenance 
rate gained weight significantly, compared to those fed a 1 × maintenance diet (Figure 2.1).  
These data demonstrates that diet is the most influential factor contributing to the growth and 
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over-all well-being of animals in a feedlot setting.  The most influential part of red meat 
production is whether animals reach intake levels sufficient enough to meet production goals; if 
these intake levels are not reached, this study shows that implantation will not serve as a means 
to ―make up‖ for the losses incurred.  Verde and Trenkle (1987) demonstrated that there are 
some differences in hormone concentrations (including growth hormone, insulin, and T4) in 
plasma from cattle that appear to be due to genetic size, as well as age.  The unknown 
background and breeding of the cattle used in this study may have been a contributing factor to 
the differences in weight gain between the four groups over the 28-day period, as well as in 
normal, non-study cattle found in feedlots across the U.S.   
 Average daily gain also did not follow the patterns seen in previous literature—while not 
statistically significant, implanted animals fed at 2 × maintenance actually had lower ADG than 
non-implanted animals fed the same amount.  The opposite was observed in those groups fed at a 
1 × maintenance diet, but this was again, not statistically significant.  The reasons stated above 
may also have been the cause of such unconventional findings in average daily gain data. 
 Plasma Urea Nitrogen 
There was a tendency for an interaction between diet and implant (P = 0.09), showing 
increased PUN values in steers fed a 2 × maintenance ration, without an implant.  Diet alone had 
a significant impact on PUN levels (P < 0.01).   According to Thomson et al. (1996), there are 
three ways in which the amount of nitrogen in the plasma of an animal can be changed: changes 
in protein synthesis, changes in protein degradation, or both.  Anabolic growth implants affect 
the element of protein synthesis in the case of beef cattle (Trenkle et al, 1987).  It does not 
increase or decrease the amount of nitrogen retained in the body, but rather increases the 
utilization of that nitrogen for the use of the aforementioned synthesis of protein (Thomson et al, 
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1996).   Because more of the body’s nitrogen store is being used in those implanted animals, it 
has been shown that urea nitrogen levels in the plasma of implanted steers versus non-implanted 
steers is lower (Thomson et al, 1996).  However, in the current study, PUN levels of implanted 
steers versus non-implanted steers were no different (Figure 2.2).  When measurements of PUN 
made by Thomson and others (1996) are compared to data from the current study, nitrogen levels 
were lower in implanted cattle in the study performed by Thomson, while implanted cattle in the 
current study showed higher PUN levels.  Differences between these data sets includes units of 
measurement of PUN, and time intervals between measurements, however, when comparing the 
data, PUN levels should follow a similar pattern, regardless of unit of measurement.  It may be 
speculated that nutrient availability had a significant biological effect on nitrogen retention, but 
the effect was not seen statistically. 
 Insulin-like Growth Factor-1 (IGF-1) 
In the current study, no significant interactions were noted between diet and implant in 
the analysis of IGF-1 levels.  However, diet had an effect on IGF-1 levels (P < 0.01), with 
increased IGF-1 levels in steers fed 2 × maintenance (Figure 2.3).  Because IGF-1 is a mediator 
of growth promotion, it is intuitive that IGF-1 levels are increased in cattle fed a 2 × maintenance 
ration.  Elasser et al. (1989) showed that diet composition and intake have an effect on the 
circulating plasma IGF-1 levels in growing steers.  However, in the current study, the IGF-1 
concentrations in implanted cattle show no difference from those in non-implanted cattle. 
IGF-1 is a peptide hormone synthesized and secreted mainly from the liver, and mediates 
the growth-promoting actions of growth hormone (Hong & Forsberg, 1994).  The anabolic 
effects of IGF-1 on skeletal muscle cells and satellite cells include stimulation of amino acid 
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uptake, protein synthesis, glucose uptake, DNA and RNA synthesis, cell proliferation, and cell 
differentiation (Hong & Forsberg, 1994, Machida & Booth, 2004).   
Johnson and others (1996) concluded that circulating levels of IGF-1 were increased in 
steers implanted with a combined TBA/E2 implant as compared to control steers given no 
implant.  It has also been shown that a combined TBA and estradiol implant can increase the 
time in which satellite cells become activated in culture (Johnson et al, 1998).  An increase in 
IGF-1 production and satellite cell activation of implanted cattle contributes to the positive 
effects of implantation on enhancing protein accretion in growing true muscle cells (Johnson et 
al, 1998).  However, again, in the current study, the IGF-1 concentrations in implanted cattle 
show no difference from those in non-implanted cattle. 
  
 Myosin Heavy Chain (MYH) 
When serum from study animals was applied to cultured cells from the 
semimembranosus muscle from a non-study steer, intake had no effect on MYH but implant 
increased MYH abundance (P<0.01) (Figure 2.4).   This demonstrates that when muscle cells are 
provided adequate nutrition, implant status does contribute to the amount of protein deposition 
that is seen within muscle cells, both in vitro and in vivo. 
The growth of skeletal muscle tissue involves a unique and complex series of events. 
Postnatal skeletal muscle growth can be attributed to both an increase in diameter and length of 
the muscle fibers.  Increase in muscle cell growth is defined as hypertrophy (Aberle et al, 1989).  
Multiple studies have shown that, postnatally, there is an increase in the amount of DNA content 
in the muscle fibers of various mammals (Winick & Noble 1966, Moss 1968, Johns & Bergen 
1976,).  This external source of DNA is the muscle satellite cell (Moss & LeBlond, 1970).   
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However, satellite cells are not in a continuous state of proliferation.  They reside in a state of 
quiescence, and must be stimulated by hormones to progress through the cell cycle.  It has been 
found that the progression factor insulin-like growth factor 1 (IGF-1) is a stimulant of this 
proliferation (Johnson et al, 1998).  The results of this study do not show the effects of 
implantation on circulating IGF-1 factors and subsequent increases in muscle hypertrophy in 
vivo, but do, however, show that skeletal muscle hypertrophy can be seen when serum from 
implanted steers is combined with cultured myocytes in a controlled and nutrient-adequate 
environment (in vitro). 
 Abundance of pERK and mTOR 
As previously mentioned, cellular growth and proliferation involves a complex series of 
events that start with signaling at the molecular level.  Some of the molecules and proteins that 
could be synthesized or activated in response to the administration of anabolic steroids include 
the mammalian target of rapamycin (mTOR) and extracellular signal-related kinases (ERK).  
The phosphorylation of these signaling proteins may indicate the ―turning on‖ or ―turning off‖ of 
cellular pathways that increase muscle protein synthesis, and therefore, muscle growth.   
The extracellular signal-related kinase (ERK) plays an important role in cell proliferation 
and differentiation (Lai et al, 2001).  The ERK cascade is the first of many signaling pathways to 
be identified in the MAP kinase family, which regulates a number of different physiologic 
processes within mammalian cells, including cell proliferation and differentiation, hypertrophy, 
apoptosis, and inflammation (Sakomoto & Goodyear, 2002).  This cascade, shown in Figure 2.5, 
is activated by growth factors, including IGF-1 (Glass, 2005).  Because implant status has been 
shown to have an effect upon IGF-1 levels, it may be speculated that changes in IGF-1 levels 
caused by implants may result in subsequent changes in phosphorylated ERK levels in skeletal 
30 
 
muscle cells.   In the case of the data collected from this set of cattle, implant increased the 
expression of pERK (P<0.01), but intake had no effect, and there was no interaction between the 
two treatments (Figure 2.6).   
The protein kinase mTOR has been shown to play an essential part in the regulation of 
many cellular activities, including transcription, translation, cell size, and protein stability 
(Corradetti & Guan, 2006).  To help regulate these processes, mTOR integrates information 
about nutrient status, energy status, and many growth factors (Sorbassov et al, 2005).  According 
to Sorbassov et al. (2005), mTOR is a central component in the regulation of cellular processes 
that determine cell growth and proliferation, and even overall animal size.  It is because of this 
integration and the effects on so many different cellular activities that mTOR could be helpful in 
determining the effects of implantation and nutrient availability in beef cattle. 
In the current study, serum from steers with 2 × maitenance intake and implant 
administration showed increased abundance of pmTOR (P=0.02) in cultured myocytes (Figure 
2.7).  There was an interaction between diet and implant on the expression of mTOR.  
Intuitively, steers receiving a 2 × maintenance diet showed higher levels of mTOR expression 
than those receiving maintenance alone, supporting the idea that mTOR is more abundant when a 
nutrient-adequate environment is present, and cellular growth and proliferation is favored.  
However, implant alone had no effect on pmTOR at restricted intake (P=0.37, interaction P < 
0.02).  Interestingly, steers fed at 1 × maintenance had similar mTOR levels, regardless of 
implant status, which is not to be expected after reviewing the current literature.  
Phopsphorylated (activated) mTOR is a molecule that has been shown to increase in abundance 
when nutrition is adequate, and actually decrease when the nutrient environment is not favorable 
for growth (Coradetti & Gaun, 2006).  In the current study, mTOR values were similar in groups 
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of non-implanted steers fed both 1 and 2 × maintenance diets, which is inconsistent with the 
current theories involving the abundance of mTOR in relation to nutrition status. 
 Conclusion 
Results of this study show that nutrient status, above all, is the most influential factor in 
the growth of skeletal muscle in cattle raised for red meat production.  With the improvements in 
efficiency and gain that anabolic growth implants have been shown to provide, and the absence 
of negative effects of implants as shown in this study, it may be speculated that implantation 
does not have a negative, or catabolic, effect on skeletal muscle cells when it comes to 
proliferation and differentiation, even in animals in a restricted nutritional state.  The molecular 
and cellular measurements made in this study have shown that implantation can improve skeletal 
muscle hypertrophy, but only in the presence of adequate nutrition.   
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Figures and Tables 
Table 2.1: Composition of grower’s ration 
 
 Wheat middlings       14.68 
Cracked corn 
   
10.73 
Corn gluten feed 
   
18.22 
Extender pellets 
   
41.82 
Cottonseed hulls 
   
7.68 
Dried distiller's grain 
   
3.01 
Molasses 
   
1.67 
Limestone       1.85 
Diet also included salt, zinc sulfate, vitamin A, and Rumensin 
80 
Total Diet Composition 
CP 
 
15.3 
Ca 
 
0.56 
P 
 
1.43 
NEm (Mcal/kg) 
 
1.44 
NEg (Mcal/kg)   0.85 
 
Table 2.2: ADG for each trial goup 
 
  Day 14 Day 28 
1 × Maintenance, Implant  0.0 0.3  
1 × Maintenance, No Implant  -0.8 -0.1  
2 × Maintenance, Implant  4.5 3.6  
2 × Maintenance, No Implant  5.5 3.6  
SEM 1.47 0.94 
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Figure 2.1: Body weight by diet and implant at day 14.  Points not bearing a common letter 
differ.  Diet had a significant effect on body weight (P < 0.0), however implant did not (P = 
0.45).  No interaction was observed (P = 0.23). 
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Figure 2.2: PUN concentration of steers implanted with a long-term TBA:E2 implant.  
There was a tendency for diet to have an effect on implant effects (P = 0.09).  Points not 
bearing a common letter differ. 
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Figure 2.3: IGF-1 concentration in steers by diet and implant.  Points not bearing a 
common letter differ.  There was no diet × implant interaction (P = 0.33), implant did not 
affect IGF-1 concentrations (P = 0.41), however nutrient status seemed to increase IGF-1 
concentrations in animals fed 2 × maintenance diet (P < 0.01). 
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Figure 2.4: Myosin heavy chain abundance in cultured myocytes from a non-study steer.  
Myocytes were treated with serum from study steers on days 28, and myosin heavy chain 
abundance was measured.  Serum from implanted cattle caused an increase in the MYH 
abundance compared to cells treated with serum from non-implanted cattle (P < 0.01), 
however, diet had no effect (P = 0.85).  Points not bearing a common letter differ. 
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Figure 2.5: ERK cascade  
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Figure 2.6: Abundance of phosphorylated ERK (in arbitrary density units) in cultured 
myocytes receiving serum from study steers.  Implant increased pERK levels in cattle, 
regardless of nutrient status (P < 0.01).  SEM = 556.2. 
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Figure 2.7: Abundance of phosphorylated mTOR (in arbitrary density units) in cultured 
myocytes receiving serum from study steers.  Diet (2 × maintenance = lighter grey) showed 
a significant effect on the mTOR levels in implanted steers (P < 0.02).  SEM = 609.2. 
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